Philippe Lambin

This study shows that deficiencies in Fanconi Anemia or homologous recombination pathways enhance the antitumor effects of CP-506, a hypoxia-activated prodrug, through synthetic lethality mechanisms.

This study evaluates how proton therapy's tumor control effectiveness varies with fractionation schedules in early-stage NSCLC, finding higher RBE for short-term treatments.

The paper presents an open-source platform hosting predictive models for COVID-19 diagnosis and prognosis, enabling clinicians to use validated models in clinical practice.

The paper introduces SIMMS, a method that identifies biomarkers by analyzing molecular data and biological networks, showing improved performance in predicting disease subtypes and outcomes.